Mastek Limited has informed stock exchanges about scheduled analyst and institutional investor meetings set for May 4, 2026, in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company filed the intimation on April 30, 2026, providing comprehensive details of the upcoming investor interactions.

Meeting Schedule and Participants

The company has arranged one-to-one investor meetings with two institutional participants in Mumbai through physical interactions. The scheduled meetings will focus on industry and company-specific developments that are already available in the public domain.

Investor Meeting Timeline

The company has scheduled meetings with two institutional investors at different times during the afternoon session, as detailed in the regulatory filing.

Regulatory Compliance and Disclosures

Mastek Limited emphasized its commitment to regulatory compliance by highlighting several key aspects of the scheduled meetings. The company specifically noted that no unpublished price sensitive information (UPSI) will be shared during the investor interactions, ensuring adherence to insider trading regulations.

The filing also mentioned that the meeting schedule may undergo changes due to exigencies on the part of the investors or the company. This flexibility clause provides both parties with the option to adjust timings if necessary while maintaining transparency with the stock exchanges.

Corporate Communication

The intimation was signed by Reena Raje, Company Secretary & Compliance Officer (Membership No. A21440), and filed under reference number SEC/011/2026-27. The company has also hosted this information on its official website at www.mastek.com , ensuring broader accessibility for all stakeholders.

Mastek Limited, incorporated with CIN L74140GJ1982PLC005215, maintains its registered office at President House, Ahmedabad, and continues to engage with institutional investors as part of its ongoing investor relations activities. The formal communication was addressed to both BSE Limited and The National Stock Exchange of India Limited, maintaining compliance with dual listing requirements.

Mastek has entered into a memorandum of understanding to sell a commercial building for ₹60 crore, the IT services company announced on April 24, 2026. This strategic asset divestment involves a substantial commercial property located at Mahindra World City SEZ in Chennai.

Transaction Details

The MOU was signed with Caresoft Mobility Private Limited for the sale of a commercial building with an approximate built-up area of 1,57,233 square feet. The property is situated on leased land measuring 15.50 acres at Mahindra World City, SEZ, Chengalpattu, Chennai.

Regulatory Compliance

Mastek has filed the requisite disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that Caresoft Mobility Private Limited does not belong to the promoter, promoter group, or group companies of Mastek, ensuring the transaction remains at arm's length.

Transaction Structure

The aggregate consideration of ₹60 crore will be received in two tranches according to the MOU terms. The transaction is subject to execution of definitive agreements and receipt of necessary approvals from relevant regulatory and statutory authorities, including SEZ compliance requirements.

Strategic Impact

This asset divestment represents a significant step in Mastek's portfolio optimization strategy. The sale of this Chennai-based commercial property will provide additional liquidity while allowing the company to focus resources on its core IT services and digital transformation operations. The transaction does not constitute disposal of an undertaking under Section 180(1)(a) of the Companies Act, 2013.